ERN1 and plasma cell myeloma: Modulators of IRE1 signaling like MKC-3946 [103], 3-methoxy-6-bromosalicylaldehyde [122], 4μ8C [123], STF-083010 [124], KIRA-6 and toyocamycin [125] are being therapeutically used in the case of multiple myeloma.